ACM
VERA icon

Aquatic Capital Management’s Vera Therapeutics VERA Stock Holding History

Aquatic Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,786
Closed -$604K – 1796
2025
Q3 		$604K Sell
20,786
-26,345
-56% -$609K 0.01% 822
2025
Q2 		$1.11M Buy
+47,131
New +$1.06M 0.02% 621
2024
Q3 		– Sell
-3,100
Closed -$112K – 1567
2024
Q2 		$112K Buy
+3,100
New +$123K ﹤0.01% 872

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Aquatic Capital Management's VERA Position: Q4 2025 in Review

Aquatic Capital Management sold out of Vera Therapeutics (VERA) in Q4 2025, closing a stake of 20,786 shares — an estimated $604K sold.

Aquatic Capital Management first reported a position in VERA in Q2 2024 and held it in 3 quarters. The position peaked at $1.11M in Q2 2025. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

  • Aquatic Capital Management reported no remaining Vera Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 20,786 Vera Therapeutics shares in Q4 2025, an estimated $604K.
  • Aquatic Capital Management first reported a position in Vera Therapeutics in Q2 2024 and held it in 3 quarters.
  • Aquatic Capital Management's Vera Therapeutics position peaked at $1.11M in Q2 2025.
  • 214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on Aquatic Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.